ReviewExpert opinion on therapeutic targets2017

Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.

Xiaoliang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.